| consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017 | 269 | 2017 |
| Systematic review: fatigue in inflammatory bowel disease DR Van Langenberg, PR Gibson Alimentary pharmacology & therapeutics 32 (2), 131-143, 2010 | 222 | 2010 |
| Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome CK Yao, HL Tan, DR Van Langenberg, JS Barrett, R Rose, K Liels, ... Journal of Human Nutrition and Dietetics 27, 263-275, 2014 | 168 | 2014 |
| A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease C Sack, VA Phan, R Grafton, G Holtmann, DR Van Langenberg, K Brett, ... Journal of Crohn's and Colitis 6 (3), 302-310, 2012 | 139 | 2012 |
| Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal? B Ye, DR van Langenberg World journal of gastrointestinal pharmacology and therapeutics 6 (4), 137, 2015 | 112 | 2015 |
| Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status RV Bryant, DR van Langenberg, GJ Holtmann, JM Andrews Journal of gastroenterology and hepatology 26 (5), 916-923, 2011 | 112 | 2011 |
| Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease L Prideaux, S Kang, J Wagner, M Buckley, JE Mahar, P De Cruz, Z Wen, ... Inflammatory bowel diseases 19 (13), 2906-2918, 2013 | 107 | 2013 |
| Objectively measured muscle fatigue in Crohn's disease: correlation with self-reported fatigue and associated factors for clinical application DR Van Langenberg, P Della Gatta, SA Warmington, DJ Kidgell, ... Journal of Crohn's and Colitis 8 (2), 137-146, 2014 | 80 | 2014 |
| Factors associated with physical and cognitive fatigue in patients with Crohn's disease: a cross-sectional and longitudinal study DR van Langenberg, PR Gibson Inflammatory Bowel Diseases 20 (1), 115-125, 2014 | 79 | 2014 |
| Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort G Morrison, DR Van Langenberg, SJ Gibson, PR Gibson Inflammatory bowel diseases 19 (6), 1210-1217, 2013 | 79 | 2013 |
| Un‐promoted issues in inflammatory bowel disease: opportunities to optimize care JM Andrews, RE Mountifield, DR Van Langenberg, PA Bampton, ... Internal medicine journal 40 (3), 173-182, 2010 | 77 | 2010 |
| Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease DR Van Langenberg, PD Gatta, B Hill, E Zacharewicz, PR Gibson, ... Journal of Crohn's and Colitis 8 (7), 626-634, 2014 | 75 | 2014 |
| Sleep and physical activity measured by accelerometry in Crohn's disease DR Van Langenberg, MC Papandony, PR Gibson Alimentary pharmacology & therapeutics 41 (10), 991-1004, 2015 | 71 | 2015 |
| Time to clinical response and remission for therapeutics in inflammatory bowel diseases: what should the clinician expect, what should patients be told? A Vasudevan, PR Gibson, DR Van Langenberg World journal of gastroenterology 23 (35), 6385, 2017 | 67 | 2017 |
| Toward an algorithm for the diagnosis and management of CMV in patients with colitis L Beswick, B Ye, DR Van Langenberg Inflammatory bowel diseases 22 (12), 2966-2976, 2016 | 61 | 2016 |
| Cognitive impairment in Crohn’s disease is associated with systemic inflammation, symptom burden and sleep disturbance DR van Langenberg, GW Yelland, SR Robinson, PR Gibson United European gastroenterology journal 5 (4), 579-587, 2017 | 58 | 2017 |
| Intra‐patient variability in adalimumab drug levels within and between cycles in Crohn's disease MG Ward, PA Thwaites, L Beswick, J Hogg, G Rosella, ... Alimentary Pharmacology & Therapeutics 45 (8), 1135-1145, 2017 | 48 | 2017 |
| Predicting response after infliximab salvage in acute severe ulcerative colitis MC Choy, D Seah, A Gorelik, YK An, CY Chen, FA Macrae, MP Sparrow, ... Journal of gastroenterology and hepatology 33 (7), 1347-1352, 2018 | 44 | 2018 |
| Exploration of predictive biomarkers of early infliximab response in acute severe colitis: a prospective pilot study L Beswick, O Rosella, G Rosella, B Headon, MP Sparrow, PR Gibson, ... Journal of Crohn's and Colitis 12 (3), 289-297, 2018 | 42 | 2018 |
| Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change DR Van Langenberg, K Lange, DJ Hetzel, GJ Holtmann, JM Andrews Journal of gastroenterology and hepatology 25 (7), 1250-1258, 2010 | 38 | 2010 |
